Macrophage Infiltration into the Glomeruli in Lipoprotein Glomerulopathy

被引:6
作者
Takasaki, Satoshi [1 ]
Maeda, Kunihiko [2 ]
Joh, Kensuke [3 ]
Yamakage, Shu [4 ]
Fukase, Sachiko [4 ]
Takahashi, Toshiyuki [4 ]
Suzuki, Masayuki [4 ]
Matsunaga, Akira [5 ]
Saito, Takao [6 ]
机构
[1] Saiseikai Yamagata Saisei Hosp, Dept Internal Med, Yamagata, Japan
[2] Yamagata Prefectural Univ Hlth Sci, Fac Hlth Sci, Dept Nursing, Yamagata, Japan
[3] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi, Japan
[4] Yamagata Prefectural Cent Hosp, Dept Internal Med, Yamagata, Japan
[5] Fukuoka Univ, Sch Med, Dept Lab Med, Fukuoka, Japan
[6] Fukuoka Univ, Sch Med, Dept Internal Med, Fukuoka, Japan
来源
CASE REPORTS IN NEPHROLOGY AND DIALYSIS | 2015年 / 5卷 / 03期
基金
日本学术振兴会;
关键词
apoE2; apoE Tokyo/Maebashi; Form cell; Lipoprotein glomerulopathy; Macrophage;
D O I
10.1159/000441715
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Lipoprotein glomerulopathy (LPG) is characterized by histopathological features showing intra-glomerular lipoprotein thrombi and type III hyperlipoproteinemia (HLP), with heterozygote mutation of apolipoprotein (apo) E gene. On the other hand, as another renal lipidosis with type III HLP, apoE2 homozygote-related glomerulopathy (apoE2-GN) showing foamy macrophages has been reported. The case of a 25-year-old man who had LPG by clinical behavior and gene analysis, but demonstrated atypical histopathological features with a substantial amount of foamy macrophage infiltration in the glomeruli, is presented. The combination of alleles for apoE Tokyo/ Maebashi and classical apoE2 (Arg158Cys) was inferred to be the leading cause of the unique renal pathology with lipoprotein thrombi and foamy macrophages. In addition, foamy macrophages infiltrated some part of the apoE-positive region within the glomerulus, but did not exist in lipoprotein thrombi despite apoE positivity, suggesting that properties of apoE are crucial in the development of LPG rather than macrophage function. This case provides important information related to the pathogenesis of LPG and apoE2-GN. (C) 2015 The Author(s) Published by S. Karger AG, Basel
引用
收藏
页码:204 / 212
页数:9
相关论文
共 15 条
  • [1] Novel Genetic Mutation in Apolipoprotein E2 Homozygosis and Its Implication in Organ Donation: A Case Report
    Cautero, N.
    Di Benedetto, F.
    De Ruvo, N.
    Montalti, R.
    Guerrini, G. P.
    Ballarin, R.
    Spaggiari, M.
    Smerieri, N.
    De Blasiis, M. G.
    Rompianesi, G.
    Iemmolo, R. M.
    Marino, M.
    Bertolotti, M.
    Zivieri, S.
    Gerunda, G. E.
    [J]. TRANSPLANTATION PROCEEDINGS, 2010, 42 (04) : 1349 - 1351
  • [2] Common Apolipoprotein E Gene Mutations Contribute to Lipoprotein Glomerulopathy in China
    Han, Jia
    Pan, Yongli
    Chen, Yuqing
    Li, Xia
    Xing, Guangqun
    Shi, Junhua
    Hou, Ping
    Zhang, Hong
    Wang, Haiyan
    [J]. NEPHRON CLINICAL PRACTICE, 2010, 114 (04): : C260 - C267
  • [3] Macrophage impairment produced by Fc receptor gamma deficiency plays a principal role in the development of lipoprotein glomerulopathy in concert with apoE abnormalities
    Ito, Kenji
    Nakashima, Hitoshi
    Watanabe, Maho
    Ishimura, Atsunori
    Miyahara, Yoshito
    Abe, Yasuhiro
    Yasuno, Tetsuhiko
    Ifuku, Masakazu
    Sasatomi, Yoshie
    Saito, Takao
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 (10) : 3899 - 3907
  • [4] Chronic graft-versus-host autoimmune disease in Fc receptor γ chain-deficient mice results in lipoprotein glomerulopathy
    Kanamuru, Y
    Nakao, A
    Shirato, I
    Okumar, K
    Ogawa, H
    Tomino, Y
    Ra, C
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2002, 13 (06): : 1527 - 1533
  • [5] Glomerulopathy with Homozygous Apolipoprotein E2: A Report of Three Cases and Review of the Literature
    Kawanishi, Kunio
    Sawada, Anri
    Ochi, Ayami
    Moriyama, Takahito
    Mitobe, Michihiro
    Mochizuki, Toshio
    Honda, Kazuho
    Oda, Hideaki
    Nishikawa, Toshio
    Nitta, Kosaku
    [J]. CASE REPORTS IN NEPHROLOGY AND DIALYSIS, 2013, 3 (02): : 128 - 135
  • [6] A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy
    Kinomura, Masaru
    Sugiyama, Hitoshi
    Saito, Takao
    Matsunaga, Akira
    Sada, Ken-ei
    Kanzaki, Motoko
    Takazawa, Yuki
    Maeshima, Yohei
    Yanai, Hiroyuki
    Makino, Hirofumi
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2008, 23 (02) : 751 - 756
  • [7] Association of a novel 3-amino acid deletion mutation of apolipoprotein E (Apo E Tokyo) with lipoprotein glomerulopathy
    Konishi, K
    Saruta, T
    Kuramochi, S
    Oikawa, S
    Saito, T
    Han, H
    Matsunaga, A
    Sasaki, J
    [J]. NEPHRON, 1999, 83 (03): : 214 - 218
  • [8] Mahley RW, 1999, J LIPID RES, V40, P1933
  • [9] A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy
    Matsunaga, A
    Sasaki, J
    Komatsu, T
    Kanatsu, K
    Tsuji, E
    Moriyama, K
    Koga, T
    Arakawa, K
    Oikawa, S
    Saito, T
    Kita, T
    Doi, T
    [J]. KIDNEY INTERNATIONAL, 1999, 56 (02) : 421 - 427
  • [10] A new variant of apolipoprotein E (apo E Maebashi) in lipoprotein glomerulopathy
    Ogawa, T
    Maruyama, K
    Hattori, H
    Arai, H
    Kondoh, I
    Egashira, T
    Watanabe, T
    Kobayashi, Y
    Morikawa, A
    [J]. PEDIATRIC NEPHROLOGY, 2000, 14 (02) : 149 - 151